Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary Note.
about
"Pro-dopamine regulation (KB220Z™)" as a long-term therapeutic modality to overcome reduced resting state dopamine tone in opiate/opioid epidemic in America.Buprenorphine Response as a Function of Neurogenetic Polymorphic Antecedents: Can Dopamine Genes Affect Clinical Outcomes in Reward Deficiency Syndrome (RDS)?Putative dopamine agonist (KB220Z) attenuates lucid nightmares in PTSD patients: role of enhanced brain reward functional connectivity and homeostasis redeeming joy.Can Genetic Testing Coupled with Enhanced Dopaminergic Activation Reduce Recidivism Rates in the Workers Compensation Legacy Cases?Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).Hypothesizing that a Pro-Dopaminergic Regulator (KB220z™ Liquid Variant) can Induce "Dopamine Homeostasis" and Provide Adjunctive Detoxification Benefits in Opiate/Opioid Dependence.Should the United States Government Repeal Restrictions on Buprenorphine/Naloxone Treatment?
P2860
Q33647561-A30424EA-9360-4EE5-9F65-F919390BC68DQ35053937-91C695B6-5AED-49B6-B6CC-8DCB437DBC50Q35847614-29F26814-1A6E-4193-AC80-0121704D8728Q37158038-427FD652-6D1C-4B34-A2DC-159400C22EBCQ39053008-6D137AA1-96C9-45F8-9249-68CA515998E9Q42375786-A75DB79B-F12E-46AB-83B7-E3CAE639DE28Q42386010-3D39CC26-9B0B-482B-85D6-AFBCACEFAFA1
P2860
Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary Note.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Withdrawal from Buprenorphine/ ...... ic Agonist: A Cautionary Note.
@en
Withdrawal from Buprenorphine/ ...... ic Agonist: A Cautionary Note.
@nl
type
label
Withdrawal from Buprenorphine/ ...... ic Agonist: A Cautionary Note.
@en
Withdrawal from Buprenorphine/ ...... ic Agonist: A Cautionary Note.
@nl
prefLabel
Withdrawal from Buprenorphine/ ...... ic Agonist: A Cautionary Note.
@en
Withdrawal from Buprenorphine/ ...... ic Agonist: A Cautionary Note.
@nl
P2093
P2860
P1476
Withdrawal from Buprenorphine/ ...... ic Agonist: A Cautionary Note.
@en
P2093
Debmalya Barh
Eric R Braverman
Joan Borsten
John Femino
John Giordano
Kenneth Blum
Kristina Dushaj
Lisa Benya
Marlene Oscar-Berman
P2860
P356
10.4172/2155-6105.1000146
P577
2013-04-01T00:00:00Z